bioRxivMolecular BiologyPreprint
TropD-Detector: A CRISPR/LbCas12a-Based system for rapid and sensitive screening of Trypanosoma cruzi in Chagas vectors and reservoirs
Luis A. Ortiz‐RodrígueziD, Rafael Cabanzo HernándeziD, Jeiczon Elim Jaimes-DueñeziD, Stelia C. Méndez‐SáncheziD, Jonny E. DuqueiD
Abstract
Chagas disease, also known as American Trypanosomiasis, is a zoonosis with global distribution caused by the parasite Trypanosoma cruzi, primarily transmitted through the feces of infected triatomines. The emergence of new cases in non-endemic areas highlights the importance of early pathogen detection in vectors and reservoirs to generate effective control strategies and establish preventive policies. The objective of this study was to design and validate a detection system of T. cruzi based on specific DNA cleavage and collateral activation using the CRISPR/LbCas12a system, targeting the genes Cytochrome B (Cytb), 18S ribosomal subunit (SR18s), and histone (H2A). This system was validated for their uses in both vectors and reservoirs of the parasite. The first step was to conduct a bioinformatic analysis of the target genes and design RNA guides for each cleavage site and primers to amplify the target region through PCR. Subsequently, we sequenced the amplified DNA target and validated the detection system using T. cruzi DNA extracted from naturally infected Rhodnius pallescens in the metropolitan area of Bucaramanga, Colombia. After standardizing the method, we tested the CRISPR/Cas system with Silvio X10/4 laboratory strain of T. cruzi and scaled up to blood samples of naturally infected Didelphis marsupialis. As a result, we observed the DNA cleavage employing the CRISPR/Cas system with Cytb guide with a sensitivity of up to 0.0475 ng/uL of provided DNA. Sequencing of the Cytb gene showed no mutations in the cleavage site. However, point mutations and indels were found in SR18S and H2A, avoiding the formation of the CRISPR/LbCas12 complex. Furthermore, we introduce the design of a fluorescent detection prototype with CRISPR/LbCas12a called "Tropical Diseases Detector" (TropD-Detector). This device operates with an excitation wavelength of 480 nm emitted by an LED and a high-pass light filter with a cutoff wavelength of 500 nm. We detected positive samples using any photographic camera system. The TropD-Detector provides a visual, viable, and sensitive method for detecting T. cruzi in both vectors and reservoirs from endemic areas.
- Citations
- 0
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- A panel of phenotypically and genotypically diverse bioluminescent: fluorescent Trypanosoma cruzi strains as a resource for Chagas disease research
F. Olmo, S. Jayawardhana, … M. D. Lewis·bioRxiv·Mar 27, 2024
- Live triatomine bug, vector of Trypanosoma cruzi (Chagas disease), found engorged in Lisbon hotel room: A first for Portugal and for Europe
Jennifer K. Peterson, Alexander Aakre Kelley, … Jader de Oliveira·bioRxiv·Feb 28, 2026
- Field Evidence of Trypanosoma cruzi Infection, Diverse Host Use and Invasion of Human Dwellings by the Chagas Disease Vector in Florida, USA
Norman L. Beatty, Chanakya R. Bhosale, … Samantha M. Wisely·PLoS neglected tropical diseasesPeer-reviewed·Jul 7, 2025
- Identification of antifungal agents AR-12 and Fosmanogepix as anti-Trypanosoma cruzi drugs through an enhanced fluorogenic β-galactosidase phenotypic screening assay
Mercedes Didier Garnham, Fátima Agüero, … Emir Salas‐Sarduy·ACS Infectious DiseasesPeer-reviewed·Jan 2, 2026
- Novel CRISPR-based detection of Leishmania species
Eva Dueñas, Jose Alberto Nakamoto, … Vanessa Adaui·Frontiers in MicrobiologyPeer-reviewed·Sep 15, 2022
- Ultra-high throughput in vitro translation assay for identification of Trypanosoma cruzi-specific protein synthesis inhibitors
Camila Colombari Mantovani, Carolina Borsoi Moraes, … Sérgio Schenkman·bioRxiv·Feb 2, 2025